- Home
- / Race Oncology
Race Oncology
Stock Price
$1.2
2024-10-29
Market Capitalization
$208 M
2024-10-29
Race Oncology Summary
Company Summary
- Overview
- Race Oncology is engaged in the research of oncology drug. It offers Fat mass and obesity associated (FTO) protein.
- Type
- Public
- Status
- Active
- Founded
- 2011
- Cybersecurity rating
- Sectors
Table of Contents
Race Oncology Financials
Summary Financials
- Gross profit (H1, 2026)
- $2.8M
- Net income (H1, 2026)
- ($4.1M)
- Cash (H1, 2026)
- $20.9M
- EBIT (H1, 2026)
- ($4.3M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026